Regulation of TGFbeta signaling pathway by microRNA miR-146b-5p in thyroid cancer.

Author(s)

Murilo Vieira Geraldo

• Document type: Doctoral Thesis
• Press: São Paulo.
• Institution: Universidade de São Paulo (USP). Instituto de Ciências Biomédicas (ICB/SDI)
• Defense date: 2011-11-23

Examining board members

Edna Teruko Kimura; Maria Luiza Morais Barreto de Chaves; Alison Colquhoun; Joao Roberto Maciel Martins; Ileana Gabriela Sanchez de Rubio

• Advisor: Edna Teruko Kimura

Abstract

MicroRNAs are small non-coding RNAs involved in post-transcriptional gene regulation. Large-scale analyses revealed that miR-146b-5p is overexpressed in papillary carcinomas (PTC), the most prevalent form of thyroid cancer. A computational analysis indicated SMAD4, an important member of the TGF-<font face=\"Symbol\">b signaling pathway, as a putative target of miR-146b-5p. The TGFbeta pathway is a negative regulator of thyroid follicular cell growth, and the mechanism by which thyroid cancer cells evade its inhibitory signal remains unclear. The overexpression of miR-146b-5p in normal follicular PCCL3 cells decreased SMAD4 levels, conferred resistance to TGFbeta anti-proliferative signal and increased cell proliferation. The specific inhibition of miR-146b-5p in papillary carcinoma cell lines significantly increased SMAD4 levels, restored the TGFbeta signal transduction and decreased cell growth. Altogether, our data confirm the oncogenic role of miR-146b-5p in thyroid follicular cells as a negative regulator of TGFbeta signaling pathway. (AU)